Betibeglogene Autotemcel Gene Therapy for Non–β <sup>0</sup> /β <sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Mark C. Walters|New England Journal of Medicine|2021Cited by 251
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Mark C. Walters, Monica Bhatia et al.|Biology of Blood and Marrow Transplantation|2017Cited by 85
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDTEugenio Marco, Kai‐Hsin Chang, Patricia Sousa et al.|Molecular Therapy|2025Cited by 3